Secuado

Active Ingredient(s): Asenapine
FDA Approved: * October 11, 2019
Pharm Company: * HISAMITSU
Category: Antipsychotic

Asenapine, sold under the brand name Saphris among others, is an atypical antipsychotic medication used to treat schizophrenia and acute mania associated with bipolar disorder.[2] It was chemically derived via altering the chemical structure of the tetracyclic (atypical) antidepressant, mianserin.[6] It was approved as a generic medication in the United States in 2020.[7] Contents 1 Medical uses 1.1 Schizophrenia 1.2 Acute mania 2 Adverse e... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Secuado 3.8 mg/D Transdermal Film, Extended Release
NDC: 68968-0172
Labeler:
Noven Therapeutics, LLC
Secuado 5.7 mg/D Transdermal Film, Extended Release
NDC: 68968-0173
Labeler:
Noven Therapeutics, LLC
Secuado 7.6 mg/D Transdermal Film, Extended Release
NDC: 68968-0174
Labeler:
Noven Therapeutics, LLC

Related Brands

Drugs with the same active ingredients